By using an experimental type 1 diabetes mouse model, it has been demonstrated that HMGB1 maintains inflammation via modulation of RAGE/AKT1/β-catenin signaling pathway in the diabetic lung [72]. This evidence concerns the gene AKT1 and type 1 diabetes mellitus.